1 Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension:The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2013, 31:1281-1357.

2 王陇德. 全国居民营养与健康状况调查2002综合报告[M]. 北京:人民卫生出版社, 2002:53-57.

3 王薇, 赵冬. 中国老年人高血压的流行病学[J]. 中华老年医学杂志, 2005, 24:246-247.

4 Nwazue VC, Raj SR. Confounders of vasovagal syncope:orthostatic hypotension[J]. Cardiol Clin, 2013, 31:89-100.

5 Aronow WS, Fleg JL, Pepine CJ, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly:a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents[J]. Circulation, 2011, 123:2434-2506.

6 Lavie L. Oxidative stress inflammation and endothelial dysfunction in obstructive sleep apnea[J]. Front Biosci (Elite Ed), 2012, 4:1391-1403.

7 Grossman E, Messerli FH. Drug-induced hypertension:an unappreciated cause of secondary hypertension[J]. Am J Med, 2012, 125:14-22.

8 Wang JG, Staessen JA, Gong L, et al. Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group[J]. Arch Intern Med, 2000, 160:211-220.

9 Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators[J]. Lancet, 1997, 350:757-764.

10 SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)[J]. JAMA, 1991, 265:3255-3264.

11 Kannel WB, D'Agostino RB, Silbershatz H. Blood pressure and cardiovascular morbidity and mortality rates in the elderly[J]. Am Heart J, 1997, 134:758-763.

12 Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older[J]. N Engl J Med, 2008, 358:1887-1898.

13 Franklin SS, Khan SA, Wong ND, et al. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study[J]. Circulation, 1999, 100:354-360.

14 Mancia G, Messerli F, Bakris G, et al. Blood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril Study[J]. Hypertension, 2007, 50:299-305.

15 Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure[J]. Hypertension, 2003, 42:1206-1252.

16 Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management:a European Society of Hypertension Task Force document[J]. J Hypertens, 2009, 27:2121-2158.

17 中国高血压防治指南修订委员会. 中国高血压防治指南2010[J]. 中华心血管病杂志, 2011, 39:579-616.

18 Insua JT, Sacks HS, Lau TS, et al. Drug treatment of hypertension in the elderly:a meta-analysis[J]. Ann Intern Med, 1994, 121:355-362.

19 National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report[J]. Circulation, 2002, 106:3143-3421.